The Nicotinic Acetylcholine Receptor: Structure and Autoimmune Pathology

References

• Abramson S. N., Li Y., Culver P., Taylor P. An analog of lophotoxin reacts covalently with Tyr190 in the alpha-subunit of the nicotinic acetylcholine receptor. J. Biol. Chem. 1989; 264: 12666–12672
   PubMedGoogle Scholar
• Adams P. R. Acetylcholine receptor kinetics. J. Memhr. Biol 1981; 58: 161–174
   PubMed Web of Science ®Google Scholar
• Aharonov A., Tarrab-Hazdai R., Abramsky O., Fuchs S. Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis. Proc. Natl. Acad. Sci. U.S.A 1975; 72: 1456–1459
   PubMedGoogle Scholar
• Akabas M. H., Stauffer D. A., Xu M., Karlin A. Acetylcholine receptor channel structure probed in cys-teine-substitution mutants. Scienc 1992; 258: 307–310
   PubMed Web of Science ®Google Scholar
• Altenbach C., Marti T., Khorana H. G., Hubbell W. L. Transmembrane protein structure: spin labeling of Bacteriorhodopsin mutants. Scienc 1990; 248: 1088–1092
   PubMed Web of Science ®Google Scholar
• Anand R., Conroy W. G., Schoepfer R., Whiting P., Lindstrom J. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem 1991; 266: 11192–11198
   PubMedGoogle Scholar
• Anderson D. J., Walter P., Blobel G. Signal recognition protein is required for the integration of acetylcholine receptor δ subunit, a transmembrane glycoprotein, into the endoplasmic reticulum membrane. J. Cell Biol 1982; 93: 501–506
   PubMed Web of Science ®Google Scholar
• Anderson D. J., Blobel G., Tzartos S. J., Gullick W., Lindstrom J. Transmembrane orientation of an early biosynthetic form of acetylcholine receptor δ sub-unit determined by proteolytic dissection in conjunction with monoclonal antibodies. J. Neurosci 1983; 3: 1773–1784
   Google Scholar
• Aronheim A., Eschel Y., Mosckovitz R., Gershoni J. M. Characterization of the binding of α-bungarotoxin to bacterially expressed cholinergic binding sites. J. Biol. Chem 1988; 263: 9933–9937
   PubMed Web of Science ®Google Scholar
• Ashwell J. D., Schwartz R. H. T Cell recognition of antigen and the la molecule as a ternary complex. Nature (London) 1986; 320: 176–179
   Google Scholar
• Atassi M. Z., Manshouri T., Yokoi T. Recognition of transmembrane regions of acetylcholine receptor subunit by antibodies, T cells and neurotoxins. FEBS Lett 1988; 228: 295–300
   Google Scholar
• Baldwin T. J., Yoshihara C. M., Blackmer K., Kinter C. R., Burden S. J. Regulation of acetylcholine receptor transcript expression during development i. Xenopus laevis. J. Cell. Biol 1988; 106: 469–478
   PubMed Web of Science ®Google Scholar
• Ballivet M., Nef P., Couturier S., Rungger D., Bader C. R., Bertrand D., Cooper E. Electrophysiology of a chick neuronal nicotinic acetylcholine receptor expressed in Xenopus oocytes after cDNA injection. Neuro 1988; 1: 847–852
   PubMed Web of Science ®Google Scholar
• Barkas T., Mauron A., Roth B., Alliod C., Tzartos S. J., Ballivet M. Mapping the main immunogenic region and toxin-binding site of the nicotinic acetylcholine receptor. Scienc 1987; 235: 77–80
   PubMed Web of Science ®Google Scholar
• Barkas T., Gabriel J. M., Mauron A., Hughes G. J., Roth B., Alliod C., Tzartos S. J., Ballivet M. Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61–76 of the α subunit. J. Biol. Chem 1988; 263: 5916–5920
   PubMed Web of Science ®Google Scholar
• Barnard E., Beeson D., Cockcroft V., Darlison M., Hicks A., Lai F., Moss S., Squire M. Molecular biology of nicotinic acetylcholine receptors from chicken muscle and brain. Nicotinic Acetylcholine Receptor, A. Maelicke. NATO-ASI, Springer-Verlag, Heidelberg 1986; Vol. 3: 389–415, H
   Google Scholar
• Beeson D., Morris A., Vincent A., Newsom-Davis J. The human muscle nicotinic acetylcholine receptor α subunit exists as two isoforms: a novel exon. EMBO J 1990; 9: 2101–2106
   PubMed Web of Science ®Google Scholar
• Bellone M., Tang F., Milius R., Conti-Tronconi B. M. The main immunogenic region of the nicotinic acetylcholine receptor. Identification of amino acid residues interacting with different antibodies. J. Immunol 1989; 143: 3568–3579
   PubMed Web of Science ®Google Scholar
• Bellone M., Ostlie N., Lei S., Conti-Tronconi B. M. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes of the a subunits of Torpedo californica and murine acetylcholine receptors. Eur. J. Immunol 1991; 21: 2203–2310
   Google Scholar
• Bellone M., Ostlie N., Karachunski P., Manfredi A. A., Conti-Tronconi B. M. Cryptic epitopes on the acetylcholine receptor are recognized by autoreactive CD4+ cells. J. Immuno 1993; 151: 1025–1030
   Google Scholar
• Bertazzon A., Conti-Tronconi B. M., Raftery M. A. Scanning tunneling microscopy imaging of Torpedo acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1992; 89: 9632–9636
   Google Scholar
• Berti F., Clementi F., Conti-Tronconi B., Folco G. A cholinoreceptor antiserum: its pharmacological properties. Br. J. Pharmacol 1976; 57: 17–22
   Google Scholar
• Bertrand D., Devillers-Thiery A., Revah F., Galzi J. L., Hussy N., Mulle C., Bertrand S., Ballivet M., Changeux J. P. Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proc. Natl. Acad. Sci. U.S.A 1992; 89: 1261–1265
   PubMedGoogle Scholar
• Besinger U. A., Toyka K. V., Homberg M., Heininger K., Hohlfeld R., Fateh-Moghadam A. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 1983; 33: 1316
   PubMed Web of Science ®Google Scholar
• Bettler B., Boulter J., Hermans-Borgmeyer I., O'Shea-Greenfield A., Deneris E. S., Moll C., Borgmeyer U., Hollmann M., Heinemann S. Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuro 1990; 5: 583–595
   PubMed Web of Science ®Google Scholar
• Betz H. Ligand-gated ion channels in the brain: the amino acid receptor superfamily. Neuro 1990a; 5: 383–392
   PubMed Web of Science ®Google Scholar
• Betz H. Homology and analogy in transmembrane channel design: lesson from synaptic membrane proteins. Biochemistr 1990b; 29: 3591–3599
   PubMed Web of Science ®Google Scholar
• Blalock A., Harvey A. M., Ford F. R., et al. Treatment of myasthenia gravis by removal of the thymus gland. J. Am. Med. Assoc 1941; 117: 1529–1533
   Google Scholar
• Blanchard S. G., Quast U., Reed K., Lee T., Schimerlik M. I., Vandlen R., Claudio T., Strader C. D., Moore H. P., Raftery M. A. Interaction of 125I-α-bungarotoxin with acetylcholine receptor fro. Torpedo californica. Biochemistr 1979; 18: 1875–1883
   PubMed Web of Science ®Google Scholar
• Blout P., Merlie J. P. Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor. Neuro 1989; 3: 349–357
   Google Scholar
• Blout P., Smith M. M., Merlie J. P. Assembly intermediates of the mouse muscle nicotinic acetylcholine receptor in stably transfected fibroblasts. J. Cell Biol 1990; 111: 2601–2611
   Google Scholar
• Boheim G., Hanke W., Barrantes F., Gibl J., Sakmann B., Fels B., Maelicke A. Agonist-activated ionic channels in acetylcholine receptor reconstituted into planar lipid bilayers. Proc. Natl. Acad. Sci. U.S.A 1981; 78: 3586–3590
   PubMed Web of Science ®Google Scholar
• Bossy B., Ballivet M., Spierer P. Conservation of neural nicotinic acetylcholine receptors from Drosophila to vertebrate central nervous systems. EMBO J 1988; 7: 611–618
   PubMed Web of Science ®Google Scholar
• Boulter J., Luyten W., Evans K., Mason P., Ballivet M., Boldman D., Stengelin S., Martin G., Heinemann S., Patrick J. Isolation of a clone coding for the a-subunit of a mouse acetylcholine receptor. J. Neurosci 1985; 5: 2545–2552
   PubMed Web of Science ®Google Scholar
• Boulter J., Evans K., Goldman D., Martin G., Treco D., Heinemann S., Patrick J. Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor α-subunit. Nature (London) 1986; 319: 368–374
   PubMed Web of Science ®Google Scholar
• Boulter J., O'Shea-Greenfield A., Duvoisin R. M., Connolly J. G., Wada E., Jensen A., Gardner P. D., Ballivet M., Deneris E. S., McKinnon D., Heinemann S., Patrick J. α3, α5, and β4: three members of the neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J. Biol. Chem 1990a; 265: 4472–4482
   PubMedGoogle Scholar
• Boulter J., Hollmann M., O'Shea-Greenfield A., Hartley M., Deneris E., Maron C., Heinemann S. Molecular cloning and functional expression of glutamate receptor subunit genes. Scienc 1990b; 249: 1033–1037
   PubMed Web of Science ®Google Scholar
• Brisson A., Unwin P. N. T. Quaternary structure of the acetylcholine receptor. Nature (London) 1985; 315: 474–477
   Google Scholar
• Brocke S., Brautbar C., Steinman T., Abramsky O., Rothbard J., Neumann D., Fuchs S., Moses E. In vivo proliferative responses and antibody titres specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J. Clin. Invest 1989; 82: 1894–1899
   Google Scholar
• Bullock K., Pomerantz W. Autonomic nervous system innervation of thymic-relayed lymphoid tissue in wildtype and nude mice. J. Comp. Neurol 1984; 228: 57–68
   Google Scholar
• Bullock K. The innervation of immune system tissues and organs. The Neuro-Immune-Endocrine Connection, C. S. Cotman, R. E. Brinton, A. Galaburda, B. McEwen, D. M. Schneider. Raven Press, New York 1987; 33–47
   Google Scholar
• Cachelin A. B., Jaggi R. β subunits determine the time course of desensitization in rat α3 neuronal nicotinic acetylcholine receptors. Pflugers Arch 1991; 419: 579–582
   PubMedGoogle Scholar
• Campbell H., Bramwell E. Myasthenia gravis. Brain 1900; 23: 277
   Google Scholar
• Cauley K., Agranhoff B. W., Goldman D. Multiple nicotinic acetylcholine receptor genes are expressed in goldfish retina and tectum. J. Neurosci 1990; 10: 670–683
   Google Scholar
• Cauley K., Agranoff B. W., Goldman D. Identification of a novel nicotinic acetylcholine receptor structural subunit expressed in goldfish retina. J. Cell Biol 1989; 108: 637–645
   PubMed Web of Science ®Google Scholar
• Cajal S. R. Histologic du Systeme Nerveux de l'Homme, Vertebres, L. Azoulay. Institute Cajal, Madrid 1911; Vol. 2, 1955. (transl)
   Google Scholar
• Changeux J. P., Devillers-Thiery A., Camouilli P. Acetylcholine receptor: an allosteric protein. Scienc 1984; 225: 1335–1345
   PubMed Web of Science ®Google Scholar
• Charnet P., Labarca C., Leonard R., Vogelaar N. J., Czyzk L., Gouin A., Davidson N., Lester H. A. An open channel blocker interacts with adjacent turns of a-helices in the nicotinic acetylcholine receptor. Neuro 1990; 4: 87–95
   Google Scholar
• Chaturvedi V., Donnelly-Roberts D. L., Lentz T. L. Substitution of Torpedo acetylcholine receptor α1-subunit residues with snake α1- and rat nerve α3-subunit residues in recombinant fusion proteins: effect on α-bungarotoxin binding. Biochemistr 1991; 31: 1370–1375
   Google Scholar
• Chavez R. A., Hall Z. W. The transmembrane topology of the amino terminus of the α subunit of the nicotinic acetylcholine receptor. J. Biol. Chem 1991; 266: 15532–15538
   Google Scholar
• Chavez R. A., Hall Z. W. Expression of fusion proteins of the nicotinic acetylcholine receptor from mammalian muscle identifies the membrane-spanning regions in the α and δ subunits. J. Cell Biol 1992; 116: 385–393
   Google Scholar
• Chiappinelli V. A. Actions of snake venom toxins on neuronal nicotinic receptors and other neuronal receptors. Pharmacol. Ther 1985; 31: 1–32
   PubMedGoogle Scholar
• Chini B., Clementi F., Hukovic N., Sher E. Neuronal-type α-bungarotoxin receptors and the α5-nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines. Proc. Natl. Acad. Sci. U.S.A 1992; 89: 1572–1576
   PubMedGoogle Scholar
• Clarke J. H., Martinez-Carrion M. Labeling of functionally sensitive sulfhydryl-containing domains of acetylcholine receptor from Torpedo californica membranes. J. Biol. Chem 1986; 261: 10063–10072
   Google Scholar
• Claudio T. Molecular genetics of acetylcholine receptor-channels. Frontiers in Molecular Biology, D. M. Glover, B. D. Hammes. IRL Press, Oxford 1989; 63–142
   Google Scholar
• Cohen J. B., Sharp S. D., Liu W. S. Structure of the agonist-binding site of the nicotinic acetylcholine receptor: [3H]-acetylcholine mustard identifies residues in the cation-binding subsite. J. Biol. Chem 1991; 266: 23354–23364
   PubMedGoogle Scholar
• Conti-Tronconi B. M., Morgutti M., Sghirlanzoni A., Clementi F. Cellular immune response against acetylcholine receptor in myasthenia gravis. I. Relevance to clinical course and pathogenesis. Neurolog 1979; 29: 496–501
   Google Scholar
• Conti-Tronconi B. M., Tzartos S., Lindstrom J. Monoclonal antibodies as a probe of acetylcholine receptor structure. II. Binding to native receptor. Biochemistr 1981; 20: 2181–2191
   PubMed Web of Science ®Google Scholar
• Conti-Tronconi B. M., Raftery M. A. The nicotinic cholinergic receptor: correlation of molecular structure with functional properties. Annu. Rev. Biochem 1982; 51: 491–530
   PubMed Web of Science ®Google Scholar
• Conti-Tronconi B. M., Hunkapiller M. W., Lindstrom J. M., Raftery M. A. Subunit structure of the acetylcholine receptor fro. Electrophorus electricus. Proc. Natl. Acad. Sci. U.S.A 1982a; 79: 6489–6493
   PubMedGoogle Scholar
• Conti-Tronconi B. M., Hunkapiller M. W., Gotti C., Raftery M. A. Mammalian muscle acetylcholine receptor: a supramolecular structure formed by four related proteins. Scienc 1982b; 218: 1227–1229
   PubMedGoogle Scholar
• Conti-Tronconi B. M., Hunkapiller M. W., Lindstrom J. W., Raftery M. A. Multisubunit composition and amino-terminal sequence of piscine muscle acetylcholine receptor. J. Receptor Res 1984; 4: 801–816
   PubMed Web of Science ®Google Scholar
• Conti-Tronconi B. M., Dunn S. M. J., Barnard E. A., Dolly J. O., Lai F. A., Ray N., Raftery M. A. Brain and muscle nicotinic acetylcholine receptors are different but homologous proteins. Proc. Natl. Acad. Sci. U.S.A 1985; 82: 5208–5212
   PubMed Web of Science ®Google Scholar
• Conti-Tronconi B. M., Raftery M. A. Nicotinic acetylcholine receptor contains multiple binding sites: evidence from binding of α-dendrotoxin. Proc. Natl. Acad. Sci. U.S.A 1986; 83: 6646–6650
   Google Scholar
• Conti-Tronconi B. M., Tzartos S., Spencer S. R., Kokla A., Tang F., Maelicke A. Identification of surface domains on the nicotinic receptor molecule by the use of toxins and antibodies. Nicotinic Acetylcholine Receptors in the Nervous System, F. Clementi, C. Gotti, E. Sher. NATO-ASI, Series H, Springer-Verlag, Berlin 1988; Vol. 25: 119–136
   Google Scholar
• Conti-Tronconi B. M., Fels G., McLane K., Tang F., Bellone M., Kokla A., Tzartos S., Milius R., Maelicke A. Use of synthetic peptides and high affinity protein ligands for structural studies of central and peripheral nicotinic receptors. Molecular Neurobiology of Neuroreceptors and Ion Channels, A. Maelicke. NATO-ASI, Series H, Springer-Verlag, Berlin 1989; Vol. 32: 291–310
   Google Scholar
• Conti-Tronconi B. M., Diethelm B. M., Wu X., Tang F., Bertazzon T., Maelicke A. α-Bungarotoxin and the competing antibody WF6 interact with different amino acids within the same cholinergic subsite. Biochemistr 1991; 30: 2575–2584
   PubMed Web of Science ®Google Scholar
• Conti-Tronconi B. M., Tang F., Diethelm B. M., Spencer S. R., Reinhardt-Maelicke S., Maelicke A. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and α-bungarotoxin. Biochemistr 1990a; 29: 6221–6230
   PubMed Web of Science ®Google Scholar
• Cooper E., Couturier S., Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature (London) 1991; 350: 235–238
   PubMed Web of Science ®Google Scholar
• Couturier S., Erkman L., Vanera S., Rungger D., Bertrand S., Boulter J., Ballivet M., Bertrand D. Alpha 5, alpha 3, and non-alpha 3. Three clustered avian genes encoding neuronal nicotinic acetylcholine receptor-related subunits. J. Biol. Chem 1990a; 265: 17560–17567
   PubMedGoogle Scholar
• Couturier S., Bertrand D., Matter J. M., Hernandez M. C., Bertrand S., Millar N., Valera S., Barkas T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homooligomeric channel blocked by alpha-BTX. Neuro 1990b; 5: 847–856
   PubMed Web of Science ®Google Scholar
• Criado M., Hochschwender S., Sarin V., Fox V. L., Lindstrom J. Evidence for unpredicted transmembrane domains in acetylcholine receptor subunits. Proc. Natl. Acad. Sci. U.S.A 1985; 82: 2004–2008
   PubMed Web of Science ®Google Scholar
• Culver P., Fenical W., Taylor P. Lophotoxin irreversibly inactivates the nicotinic acetylcholine receptor by preferential association at one of the two primary agonist sites. J. Biol. Chem 1984; 259: 3763–3770
   Google Scholar
• Culver P., Burch M., Potenza C., Wasserman L., Fenical W., Taylor P. Structure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones. Mol. Pharamcol 1985; 28: 436–444
   Google Scholar
• Czajkowski C., Karlin A. Agonist binding site of Torpedo electric tissue nicotinic acetylcholine receptor: a negatively charged region of the δ subunit within 0.9 nm of the α subunit binding site disulfide. J. Biol. Chem 1991; 266: 22603–22612
   PubMedGoogle Scholar
• Dale H. H. The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharmacol. Exp. Ther 1914; 6: 147–190
   Google Scholar
• Dale H. H. Pharmacology and nerve endings. Proc. R. Soc. Med 1935; 28: 319–332
   PubMedGoogle Scholar
• Dale H. H., Feldberg W. Chemical transmission at motor nerve ending in voluntary muscle. J. Physiol. 1934; 81: 39
   Google Scholar
• Dani J. A. Site-directed mutagenesis and single-channel currents define the ionic channel of the nicotinic acetylcholine receptor. Trends Neurosci 1989; 12: 125–128
   PubMed Web of Science ®Google Scholar
• Das M. K., Lindstrom J. The main immunogenic region of the nicotinic acetylcholine receptor. Interaction of monoclonal antibodies with synthetic peptides. Biochem. Biophys. Res. Commun 1989; 165: 865–871
   PubMed Web of Science ®Google Scholar
• Davies D. R., Sheriff S., Padlan E. A. Antibody-antigen complex. J. Biol. Chem 1988; 263: 10541–10544
   PubMed Web of Science ®Google Scholar
• Davis M. M., Bjorkman P. J. T cell antigen receptor genes and T cell recognition. Nature (London) 1988; 334: 395–402
   PubMed Web of Science ®Google Scholar
• Deneris E. S., Connolly J., Boulter J., Wada E., Wada K., Swanson L. W., Patrick J., Heinemann S. Primary structure and expression of β2: a novel subunit of neuronal nicotinic acetylcholine receptors. Neuro 1988; 1: 45–54
   PubMedGoogle Scholar
• Deneris E. S., Boulter J., Swanson L. W., Patrick J., Heinemann S. β3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain. J. Biol. Chem 1989; 264: 6268–6272
   PubMedGoogle Scholar
• Deneris E. S., Connolly J., Rogers S. W., Duvoisin R. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol. Sci 1991; 12: 34–40
   PubMed Web of Science ®Google Scholar
• Dennis M., Giraudat J., Kotzba-Hibert F., Goeldner M., Hirth C., Chang J. Y., Lazure C., Shretien M., Changeux J. P. Amino acids of the Torpedo marmorata acetylcholine receptor α subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistr 1988; 27: 2346–2357
   PubMed Web of Science ®Google Scholar
• Devillers-Thiery A., Giraudat J., Bentaboulet M., Changeux J. P. Complete mRNA coding sequence of the acetycholine binding α-subunit of Torpedo marmorata acetylcholine receptor. A model for the transmembrane organization of the polypeptide chain. Proc. Natl. Acad. Sci. U.S.A 1983; 80: 2067–2071
   PubMed Web of Science ®Google Scholar
• Dice J. F. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem. Sci 1990; 15: 305–309
   PubMed Web of Science ®Google Scholar
• DiPaola M., Czajkowski C., Bodkin M., Karlin A. The C terminus of the Torpedo acetylcholine receptor δ subunit is extracellular. Soc. Neurosci. Abstr. 1988; 14(260.5)640
   Google Scholar
• DiPaola M., Czajkowski C., Karlin A. The sidedness of the COOH terminus of the acetylcholine receptor delta subunit. J. Biol. Chem 1989; 264: 15457–15463
   Google Scholar
• DiPaola M., Kao P. N., Karlin A. Mapping the α-subunit site photolabeled by the non-competitive inhibitor [3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor. J. Biol. Chem 1990; 265: 11017–11029
   PubMed Web of Science ®Google Scholar
• Donnelly-Roberts D. L., Lentz T. L. Binding sites for α-bungarotoxin and the noncompetitive inhibitor phencyclidine on a synthetic peptide comprising residues 172–227 of the α-subunit of the nicotinic acetylcholine receptor. Biochemistr 1991; 30: 7484–7491
   PubMedGoogle Scholar
• Dougherty D. A., Stauffer D. A. Acetylcholine binding by a synthetic receptor: implications for biological recognition. Scienc 1990; 250: 1558–1560
   PubMed Web of Science ®Google Scholar
• Drachman D. B., DeSilva S., Ramsay D., Pestronk A. Humoral pathogenesis of myasthenia gravis. Ann. N.Y. Acad. Sci 1987; 505: 90–105
   PubMedGoogle Scholar
• Dunn S. M. J., Conti-Tronconi B. M., Raftery M. A. Acetylcholine receptor dimers are stabilized by extracellular disulphide bonding. Biochem. Biophys. Res. Commun 1986; 139: 830–837
   Google Scholar
• Dunn S. M. J., Conti-Tronconi B. M., Raftery M. A. A high affinity site for acetylcholine occurs close to the α/γ subunit interface of Torpedo nicotinic acetylcholine receptor. Biochemistr 1993; 32: 8616–8621
   Google Scholar
• Duvoisin R. M., Deneris E. S., Patrick J., Heinemann S. The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit. Neuro 1989; 3: 487–496
   PubMed Web of Science ®Google Scholar
• Dwyer D. S., Bradley R. J., Oh S. J., Kearney J. F. Idiotypes in myasthenia gravis. Idiotypes in Biology and Medicine, D. S. Dwyer. Academic Press, New York 1984
   Google Scholar
• Dwyer B. P. Topological dispositions of Lysine α380 and Lysine γ486 in the acetylcholine receptor fro. Torpedo californica. Biochemistr 1991; 30: 4105–4112
   Google Scholar
• Egebjerg J., Bettler B., Hermans-Borgmeyer I., Heinemann S. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not by AMPA. Nature (London) 1991; 351: 745–748
   PubMed Web of Science ®Google Scholar
• Engel A. G., Santa T. Histomeric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann. N.Y. Acad. Sci 1971; 183: 46–63
   Google Scholar
• Engel W. K., Trotter J. L., McFarlin D. E., McIntosh C. L. Thymic epithelial cell contains acetylcholine receptor. Lance 1977; 1: 1310–1311
   PubMedGoogle Scholar
• Engel A. G., Sahashi K., Fumagalli G. The immunopathology of acquired myasthenia gravis. Myasthenia gravis: pathophysiology and management, David Grob. Ann. N.Y. Acad. Sci, 1981; 377: 158–174
   Google Scholar
• Engel A. G. Myasthenia gravis and myasthenic syndromes. Ann. Neurol. 1984; 16: 519
   PubMed Web of Science ®Google Scholar
• Engel A. G. The molecular biology of end plate diseases. The Vertebrate Neuromuscular Junction, M. M. Salpeter. Alan R. Liss, New York 1987; 361–424
   Google Scholar
• Evoli A., Bartoccioni E., Barocchi A. P., Scuderi F., Tonali P. Anti-AChR-antibody negative myasthenia gravis: clinical and immunological features. Clin. Invest. Med 1989; 12: 104–109
   Google Scholar
• Fairclough R. H., Finer-Moore J., Love R. A., Kristofferson D., Desmeules P. J., Stroud R. M. Subunit organization and structure of an acetylcholine receptor. Cold Spring Harbor Symp. Quant. Biol 1983; 48: 9–20
   Google Scholar
• Falke J. J., Danburg A. F., Stemhag D., Zalkin N., Milligan D., Koshland D. E. Structure of a bacterial sensory receptor. A site-directed sulfhydryl study. J. Biol. Chem 1988; 263: 14850–14853
   Google Scholar
• Fatt P., Katz B. An analysis of the end-plate potential recorded with an intra-cellular electrode. J. Physiol 1951; 115: 320–370
   PubMed Web of Science ®Google Scholar
• Fels G., Plumer-Wilk R., Schreiber H., Maelicke A. A monoclonal antibody interfering with binding and response of the acetylcholine receptor. J. Biol. Chem 1986; 261: 15746–15754
   PubMed Web of Science ®Google Scholar
• Felten D. L., Felten S. Y., Carlson S. L., Ulschowska J. A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 1985; 135: 755s–756s
   PubMed Web of Science ®Google Scholar
• Finer-Moore J., Stroud R. Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1984; 81: 155–159
   PubMed Web of Science ®Google Scholar
• Fraenkel Y., Gershoni J. M., Navon G. Acetylcholine interactions with tryptophan-184 of the alpha-subunit of the nicotinic acetylcholine receptor revealed by transferred nuclear Overhauser effect. FEBS Lett 1991; 291: 225–228
   PubMedGoogle Scholar
• Fuchs S., Barchan D., Kachalsky S., Neumann D., Aladjem M., Vogel Z., Ovadia M., Kochva E. Molecular evolution of the binding site of the acetylcholine receptor. Myasthenia gravis and related disorders, A S. Penn, D. P. Richman, R. L. Ruff, V. A. Lennon. Ann. N.Y. Acad. Sci, 1993; 681: 126–139
   Google Scholar
• Galzi J. L., Revah F., Black D., Goeldner M., Hirth C., Changeux J. P. Identification of a novel amino acid α-tyrosine 93 within the cholinergic ligandsbinding sites of the acetylcholine receptor by photoaffinity labeling. Additional evidence for a three-loop model of the cholinergic ligands-binding sites. J. Biol. Chem 1990; 265: 10430–10437
   PubMed Web of Science ®Google Scholar
• Galzi J. L., Revah F., Bessis A., Changeux J. P. Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain. Annu. Rev. Pharmacol 1991; 31: 37–72
   Google Scholar
• Gammon G., Sercarz E. E. How some T-cells escape tolerance induction. Nature (London) 1989; 342: 183–185
   PubMedGoogle Scholar
• Gammon G., Sercarz E. E. Does the presence of self-reactive T cells indicate the breakdown of tolerance. Clin. Immunol. Immunopathol 1990; 56: 287–297
   PubMedGoogle Scholar
• Gershoni J. M., Hawrot E., Lentz T. L. Binding of α-bungarotoxin to isolated α subunit of the acetylcholine receptor of Torpedo californica: quantitative analysis with protein blots. Proc. Natl. Acad. Sci. U.S.A 1983; 80: 4973–4977
   Google Scholar
• Geuder K. I., Marx A., Witzemann V., Schalke B., Toka K. V., Kirchner T., Müller-Hermelink H. K. Pathogenetic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis. Dev. Immunol 1992; 2: 69–75
   Google Scholar
• Ghosh P., Stroud R. M. Ion channels formed by a highly charged peptide. Biochemistr 1991; 30: 3551–3557
   Google Scholar
• Gilman A. G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem 1987; 56: 615–649
   PubMed Web of Science ®Google Scholar
• Giraudat J., Dennis M., Heidmann T., Chang J. Y., Changeux J. P. Structure of the high affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the δ subunit is labelled by [3H]chlorpromazine. Proc. Natl. Acad. Sci. U.S.A 1986; 83: 2719–2723
   PubMedGoogle Scholar
• Giraudat J., Dennis M., Heidmann T., Haumont P. Y., Lederer F., Changeux J. P. Structure of the high affinity site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the β and δ chains. Biochemistr 1987; 26: 2410–2418
   PubMed Web of Science ®Google Scholar
• Giraudat J., Galzi J. L., Revah F., Changeux J. P., Haumont P. V., Lederer F. The noncompetitive blocker [3H]chlorpromazine labels segment M2 but not segment M1 of the nicotinic acetylcholine receptor α-subunit. FEBS Lett 1989; 253: 190–198
   PubMedGoogle Scholar
• Goldman D., Simmons D., Swanson L. W., Patrick J., Heinemann S. Mapping of brain areas expressing RNA homologous to two different acetylcholine receptor α-subunit cDNAs. Proc. Natl. Acad. Sci. U.S.A 1986; 86: 4076–4080
   Google Scholar
• Goldman D., Deneris E., Luyten W., Kochlar A., Patrick J., Heinemann S. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cel 1987; 48: 965–973
   PubMed Web of Science ®Google Scholar
• Goldman D., Tanai K. Coordinate regulation of RNAs encoding two isoforms of rat muscle nicotinic acetylcholine receptor β-subunit. Nucleic Acids Res 1989; 25: 3049–3056
   Google Scholar
• Gotti C., Mazzola G., Longhi R., Fornasari D., Clementi F. The binding site for α-bungarotoxin resides in the sequence 188–201 of the α-subunit of acetylcholine receptor: structure, conformation and binding characteristics of peptide [Lys] 188–201. Neurosci. Lew 1987; 82: 113–119
   Google Scholar
• Gotti C., Frigerio F., Bolognesi R., Longhi R., Racchetti G., Clementi F. Nicotinic acetylcholine receptor: a structural model for alpha-subunit peptide 188–201, the putative binding site for cholinergic agents. FEBS Lett 1988; 228: 118–122
   Google Scholar
• Granato D. A., Fulpius B. W., Moody J. F. Experimental myasthenia in Balb/c mice immunized with rat acetylcholine receptor from rat denervated muscle. Proc. Natl. Acad. Sci. U.S.A 1986; 73: 2872–2875
   Google Scholar
• Grant G. A., Frazier M. W., Chiappinelli V. A. Amino acid sequences of k-flavotoxin: establishment of a new family of snake venom neurotoxins. Biochemistr 1988; 27: 3794–3798
   PubMed Web of Science ®Google Scholar
• Gray W. R., Olivera B. M., Cruz L. J. Peptide toxins from venomous conus snails. Annu. Rev. Biochem 1988; 57: 665–700
   PubMed Web of Science ®Google Scholar
• Griesman G. E., McCormick D. J., De Aizpurua H. J., Lennon V. A. α-Bungarotoxin binds to human acetylcholine receptor α-subunit peptide 185–199 in solution and solid phase but not to peptides 125–147 and 389–409. J. Neurochem 1990; 54: 1541–1547
   PubMed Web of Science ®Google Scholar
• Myasthenia gravis, D. Grob. Ann. N.Y. Acad. Sci. 1987; 274
   Google Scholar
• Gross A., Ballivet M., Rungger D., Bertrand D. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes: role of the α subunit in agonist sensitivity and desensitization. Pflugers Arch 1991; 419: 545–551
   PubMedGoogle Scholar
• Gu Y., Hall Z. W. Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle. Neuro 1988; 1: 117–125
   PubMed Web of Science ®Google Scholar
• Gu Y., Forsayeth J. R., Verrall S., Yu X. M., Hall Z. W. Assembly of the mammalian muscle acetylcholine receptor in transfected COS cells. J. Cell Biol 1991; 114: 799–807
   PubMed Web of Science ®Google Scholar
• Gullick W. J., Lindstrom J. M. Mapping the binding of monoclonal antibodies to the acetylcholine receptor fro. Torpedo californica. Biochemistr 1983; 22: 3312–3320
   PubMed Web of Science ®Google Scholar
• Gundelfinger E. D. How complex is the nicotinic receptor system of insects. Trends Neurosci 1992; 15: 206–211
   PubMedGoogle Scholar
• Guy R. A structural model of the acetylcholine receptor channel based on partition energy and helix packing calculation. Biophys. J 1983; 45: 249–261
   Google Scholar
• Haggerty J. G., Froehner S. C. Restoration of the 125I-α-bungarotoxin binding activity to the α subunit of Torpedo acetylcholine receptor isolated by gel electrophoresis in sodium dodecyl sulfate. J. Biol. Chem 1981; 256: 8294–8297
   Google Scholar
• Hall Z. W., Gorin P. D., Silberstein L., Bennet C. A postnatal change in the immunological properties of the acetylcholine receptor at the rat muscle endplate. J. Neurosci 1985; 5: 730–734
   Google Scholar
• Harcourt G. C., Sommer N., Rothbard J., Wilcox H. N. A., Newson-Davis J. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J. Clin. Invest 1988; 82: 1295–1300
   PubMed Web of Science ®Google Scholar
• Hartman D. S., Claudio T. Coexpression of two distinct muscle acetylcholine receptor α subunits during development. Nature (London) 1990; 343: 372–373
   PubMed Web of Science ®Google Scholar
• Herb A., Burnashev N., Werner P., Sakmann B., Wisden W., Seeburg P. H. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuro 1992b; 8: 775–785
   PubMed Web of Science ®Google Scholar
• Herb A., Wisden W., Luddens H., Puia G., Vicini S., Seeburg P. H. The third γ subunit of the α-aminobutyric acid type A receptor family. Proc. Natl. Acad. Sci. U.S.A 1992a; 89: 1433–1437
   Google Scholar
• Hermsen B., Heiermann R., Maelicke A. Cloning and expression of ganglionic nAChR genes fro. Locusta migratoria. Biol. Chem. Hoppe-Seyle 1991; 372: 891–899
   Google Scholar
• Hodgking A. L., Huxley A. F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (London) 1952; 117: 500–544
   Google Scholar
• Hodgking A. L., Katz B. The effect of sodium ions on the electrical activity of the giant axon of the squid. J. Physiol. (London) 1949; 108: 37–77
   Google Scholar
• Hohlfeld R., Toyka K. V., Heininger K., Grosse-Wilde H., Kalies I. Autoimmune human T-lymphocytes specific for acetylcholine receptor. Nature (London) 1984; 310: 244–246
   PubMed Web of Science ®Google Scholar
• Hohlfeld R., Conti-Tronconi B. M., Kalies I., Bertrams J., Toyka K. V. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis. J. Immunol 1985; 135: 2393–2399
   PubMedGoogle Scholar
• Hohlfeld R., Kalies I., Kohleisen B., Heininger K., Conti-Tronconi B. M., Toyka K. V. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T-cell lines. Neurolog 1986; 36: 618–621
   PubMed Web of Science ®Google Scholar
• Hohlfeld R., Toyka K. V., Tzartos S. J., Carson W., Conti-Tronconi B. M. Human T helper lymphocytes in myasthenia gravis recognize the nicotinic receptor a subunit. Proc. Natl. Acad. Sci. U.S.A 1987; 84: 5379–5382
   PubMed Web of Science ®Google Scholar
• Hollmann M., O'Shea-Greenfield A., Rogers S. W., Heinemann S. Cloning by functional expression of a member of the glutamate receptor family. Nature (London) 1989; 342: 643–648
   PubMed Web of Science ®Google Scholar
• Hoppe H. H. Ein Beitrag zur Kennstnis der Bulbarparalyse. Berl. Klin. Wochenschr 1892; 29: 332–336
   Google Scholar
• Horton R. M., Manfredi A. A., Conti-Tronconi B. M. The 'embryonic' gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle. Neurolog 1993; 43: 983–986
   PubMedGoogle Scholar
• Hucho F. The nicotinic acetylcholine receptor and its ion channel. Eur. J. Biochem 1986; 158: 211–226
   PubMedGoogle Scholar
• Hucho F., Oberthür W., Lottspeich F. The ion channel of the nicotinic acetylcholine receptor is formed by homologous helices M II of the receptor subunits. FEBS Lett 1986; 205: 137–142
   PubMed Web of Science ®Google Scholar
• Huganir R. L., Racker E. Properties of proteoliposomes reconstituted with acetylcholine receptors fro. Torpedo californica. J. Biol. Chem 1982; 257: 9372–9378
   PubMed Web of Science ®Google Scholar
• Hulme E. C., Birdsall N. J. M., Buckley N. J. Muscarinic acetylcholine receptor subtypes. Annu. Rev. Pharmacol. Toxicol 1990; 30: 633–673
   PubMed Web of Science ®Google Scholar
• Imoto K., Methfessel C., Sakmann B., Mishina M., Moti Y., Konno T., Fukuda K., Kurasaki M., Bujo H., Fujita Y., Numa S. Location of a δ-subunit region determining ion transport through the acetylcholine receptor channel. Nature (London) 1986; 324: 670–674
   PubMed Web of Science ®Google Scholar
• Imoto K., Busch C., Sakmann B., Mishina M., Konno T., Nakai J., Bujo H., Mori Y., Fukada K., Numa S. Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature (London) 1988; 335: 645–648
   PubMed Web of Science ®Google Scholar
• Imoto K. J., Konno T., Nakai J., Wang F., Misha M., Numa S. A ring of uncharged polar amino acids as a component of channel constriction in the nicotinic acetylcholine receptor. FEBS Lett 1991; 289: 193–200
   Google Scholar
• Iwasaki Y., Kinoshita M., Ikeda K., Takamiya K., Shiojima T. Cognitive dysfunction in myasthenia gravis. Int. J. Neurosci 1990; 54: 29–33
   PubMed Web of Science ®Google Scholar
• Jakes K. S., Abrams C. K., Finkelstein A., Slatin S. L. Alteration of the pH-dependent ion sensitivity of the colcin E1 channel by site-directed mutagenesis. J. Biol. Chem. 1990; 265: 6984
   Google Scholar
• Kahinski H. J., Maas E., Spiegel P., Ruff R. L. Why are eye muscles frequently involved in myasthenia gravis. Neurolog 1990; 40: 1663–1669
   Google Scholar
• Kaminski H. J., Fenstermaker R., Ruff R. L. Adult extraocular and intercostal muscle express the γ subunit of fetal AChR. Biophysics 1991; 59: 444a, (Abstr.)
   Google Scholar
• Kao I., Drachman D. B. Thymus muscle cells bear acetycholine receptors: possible relation to myasthenia gravis. Scienc 1977; 195: 74–75
   PubMed Web of Science ®Google Scholar
• Kao P. N., Dwork A. J., Kaldany R. R. J., Silver M. L., Wideman J., Stein S., Karlin A. Identification of the half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site. J. Biol. Chem 1984; 259: 11662–11665
   PubMed Web of Science ®Google Scholar
• Kao P. N., Karlin A. Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues. J. Biol. Chem 1986; 261: 8085–8088
   PubMedGoogle Scholar
• Karlin A., Kao P. N., Dipaola M. Molecular pharmacology of the nicotinic acetylcholine receptor. Trends Pharmacol. Sci 1986; 7: 304–308
   Google Scholar
• Katz B., Miledi R. Further observations on acetylcholine noise. Nature (London) 1971; 232: 124–126
   Google Scholar
• Kawanami S., Conti-Tronconi B. M., Racs J., Raftery M. A. Isolation and characterization of nicotinic acetylcholine receptor-like protein from fetal calf thymus. J. Neurol. Sci 1988; 87: 195–209
   Google Scholar
• Keinanen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T. A., Sakmann B., Seeburg P. H. A family of AMPA-selective glutamate receptors. Scienc 1990; 249: 556–560
   PubMed Web of Science ®Google Scholar
• Kellaris K. V., Ware D. K., Smith S., Kyte J. Assessment of the number of free cysteines and isolation and identification of cystine-containing peptides from acetylcholine receptor. Biochemistr 1989; 28: 3469–3482
   PubMedGoogle Scholar
• Killen J. A., Hochschwender S. M., Lindstrom J. M. The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies of a predominant idiotope. J. Neuroimmunol 1985; 9: 229–233
   PubMed Web of Science ®Google Scholar
• Kipling R. The Jungle Book. Harper and Brothers, New York 1895
   Google Scholar
• Kirchner T., Tzartos S., Hoppe F., Schalke B., Wekerle H., Muller-Hermelink H. K. Pathogenesis of myasthenia gravis: acetylcholine receptor-related antigenic determinant in tumor-free thymuses and thymic epithelial tumors. Am. J. Pathol 1988; 130: 268–280
   PubMed Web of Science ®Google Scholar
• Kistler J., Stroud R. M., Klymkowsky M. W., Lalancette R. A., Fairclough R. H. Structure and function of an acetylcholine receptor. Biophys. J 1982; 37: 371–383
   PubMed Web of Science ®Google Scholar
• Konno T., Busch C., Von Kitzing E., Imoto K., Wang F., Nakai J., Mishina M., Numa S., Sakmann B. Rings of anionic amino acids as structural determinants of ion selectivity in the acetylcholine receptor channel. Proc. R. Soc. London Ser. 1991; 244: 69–79
   Google Scholar
• Kordossi A. A., Tzartos S. J. Conformation of cytoplasmic segments of acetylcholine receptor α- and β-subunits probed by monoclonal antibodies: sensitivity of the antibody competition approach. EMBO J 1987; 6: 1605–1610
   PubMed Web of Science ®Google Scholar
• Kubo T., Noda M., Takai T., Tanabe T., Kayano T., Shimizu S., Tanaka K., Takahashi H., Hirose T., Inayama S., Kikuno R., Miyata T., Numa S. Primary structure of the δ-subunit precursor of calf muscle acetylcholine receptor deduced from cDNA sequence. Eur. J. Biochem 1985; 149: 5–13
   PubMedGoogle Scholar
• Kurosaki T., Fukuda K., Konno T., Mori Y., Tanaka K. L., Misha M., Numa S. Functional properties of nicotinic acetylcholine receptor subunits expressed in various combinations. FEBS Lett 1987; 14: 253–258
   Google Scholar
• Land B. R., Saltpeter E. E., Saltpeter M. M. Kinetic parameters for acetylcholine interaction in intact neuromuscular junction. Proc. Natl. Acad. Sci. U.S.A 1981; 78: 7200–7204
   Google Scholar
• Langley J. N. On nerve endings and on special excitable substances in cells. Proc. R. Soc. London Ser. B 1906; 78: 170–194
   Google Scholar
• LaRochelle W. J., Wray B. E., Sealock R., Froehner S. C. Immunochemical demonstration that amino acids 360–377 of the acetylcholine receptor gamma-subunit are cytoplasmic. J. Cell Biol 1985; 100: 684–691
   PubMedGoogle Scholar
• Lehmann P. V., Forsthuber T., Miller A., Sercarz E. E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (London) 1992; 358: 155–157
   PubMed Web of Science ®Google Scholar
• Lei S. J., Raftery M. A., Conti-Tronconi B. M. Monoclonal antibodies against synthetic sequences of the nicotinic receptor cross-react fully with the native receptor, and reveal the transmembrane disposition of their epitopes. Biochemistr 1993; 32: 91–100
   Google Scholar
• Lennon V. A., Lambert E. H. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature (London) 1980; 285: 238–340
   PubMed Web of Science ®Google Scholar
• Lennon V. A., Griesman G. E. Evidence against acetylcholine receptor having a main immunogenic region as a target for autoantibodies in myasthenia gravis. Neurolog 1989; 39: 1069–1076
   PubMed Web of Science ®Google Scholar
• Lentz T. L., Wilson P. T. Neurotoxin-binding site on the acetylcholine receptor. Int. Rev. Neurobiol 1988; 29: 117–160
   PubMed Web of Science ®Google Scholar
• Leonard R. J., Labarca C. G., Charnet P., Davidson N., Lester H. A. Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor. Scienc 1988; 242: 1578–1581
   PubMed Web of Science ®Google Scholar
• Levinson A. I., Zweiman B., Lisak R. P. Immunopathogenesis and treatment of myasthenia gravis. J. Clin. Immunol 1987; 7: 187–197
   Google Scholar
• Lindstrom J., Engel M. A., Seybold M., Lennon V. A., Lambert E. H. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies. J. Exp. Med 1976; 144: 739–742
   PubMed Web of Science ®Google Scholar
• Lindstrom J., Merlie J., Yogeeswaran G. Biochemical properties of acetylcholine receptor subunits fro. Torpedo californica. Biochemistr 1979; 18: 4465–70
   PubMed Web of Science ®Google Scholar
• Lindstrorm J., Criado M., Hochschwener S., Fox J. L., Sarin V. Immunochemical tests of acetycholine receptor subunit models. Nature (London) 1984; 311: 573–575
   Google Scholar
• Lindstrom J., Schoepfer R., Whiting P. Molecular studies on the neuronal nicotinic acetylcholine receptor family. Mol. Neurobiol 1987; 1: 281–337
   PubMed Web of Science ®Google Scholar
• Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis. Adv. Immunol 1988; 42: 233–284
   PubMed Web of Science ®Google Scholar
• Listerud M., Brussaard A. B., Devay P., Colman D. R., Role L. W. Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides. Scienc 1991; 254: 1518–1521
   PubMedGoogle Scholar
• Loewi D. Über humorale übertragharkeit der herznarvenwirknug. Pflügers Arch. Ges. Physiol 1921; 189: 239–242
   Google Scholar
• Loring R. H., Chiappinelli V. A., Zigmond R. E., Cohen J. B. Characterization of a snake venom neurotoxin which blocks nicotinic transmission in the avian ciliary ganglion. Neuroscienc 1984; 11: 989–999
   PubMed Web of Science ®Google Scholar
• Lu C. Z., Link H., Mo X. A., et al. Anti-presynaptic membrane receptor antibodies in myasthenia gravis. J. Neurol. Sci 1991; 102: 39–45
   PubMed Web of Science ®Google Scholar
• Luetje C. W., Wada K., Rogers S., Abramson S. N., Tsuji K., Heinemann S., Patrick J. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptors. J. Neurochem 1990a; 55: 632–640
   PubMed Web of Science ®Google Scholar
• Luetje C. W., Patrick J., Seguela P. Nicotine receptors in the mammalian brain. FASEB J 1990b; 4: 2753–2760
   PubMed Web of Science ®Google Scholar
• Luetje C. W., Patrick J. Both alpha and beta subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci 1991; 11: 837–845
   PubMed Web of Science ®Google Scholar
• Luetje C. W., Piattoni M., Patrick J. Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric alpha subunits. Mol. Pharmacol 1992; 44: 657–666
   Google Scholar
• Maelicke M. A. Structure and function of the nicotinic acetylcholine receptor. Handbook of Experimental Pharmacology: The Cholinergic Synapse, V. P. Whittaker. Springer- Verlag, Berlin 1988; Vol. 86: 267–300
   Google Scholar
• Maelicke M. A., Plumer-Wilk R., Fels G., Spencer S. R., Engelhard M., Veltel D., Conti-Tronconi B. M. Epitope mapping employing antibodies raised against short synthetic peptides: a study of the nicotinic acetylcholine receptor. Biochemistr 1989; 29: 1396–1405
   Google Scholar
• Magni F., Bruschi F., Kasti M. The afferent innervation of the thymus gland in the rat. Brain Res 1987; 424: 379–385
   Google Scholar
• Manfredi A. A., Bellone M., Protti M. P., Conti-Tronconi B. M. Molecular mimicry among human autoantigens. Immunol. Toda 1991; 12: 46–47
   Google Scholar
• Manfredi A. A., Protti M. P., Wu X. D., Howard J. F., Jr., Conti-Tronconi B. M. CD4+ T epitope repertoire on the human acetylcholine receptor α subunit in severe myasthenia gravis. A study with synthetic peptides. Neurolog 1992; 42: 1092–1100
   PubMed Web of Science ®Google Scholar
• Manfredi A. A., Protti M. P., Dalton M. W., Howard J. F., Jr, Conti-Tronconi B. M. T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the γ and δ subunits. J. Clin. Invest 1993; 92: 1055–1067
   Google Scholar
• Manfredi A. A., Yuen M. H., Moiola L., Protti M. P., Conti-Tronconi B. M. Human acetylcholine receptor presentation in myasthenia gravis: DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. J. Immunol, in press
   Google Scholar
• Marshall J., Buckingham S. D., Shingai R., Lunt G. G., Goosey M. W., Darlison M. G., Sattelle D. B., Barnard E. A. Sequence and functional expression of a single alpha subunit of an insect nicotinic acetylcholine receptor. EMBO J 1990; 9: 4391–4398
   PubMed Web of Science ®Google Scholar
• Martin R., Jaraquemada D., Flerlage M., Richard J., Whittaker J., Long E. O., McFarline D. E., McFarland H. F. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol 1990; 145: 540–548
   PubMed Web of Science ®Google Scholar
• McCormick D. J., Atassi M. Z. Localization and synthesis of the acetylcholine-binding site in the α-chain of the Torpedo californica acetylcholine receptor. Biochem. J 1984; 224: 995–1000
   PubMed Web of Science ®Google Scholar
• McCrea P. D., Popot J. L., Engelman D. M. Transmembrane topography of the nicotinic acetylcholine receptor δ subunit. EMBO J 1987; 6: 3619–3626
   Google Scholar
• McLane K. E., Tang F., Conti-Tronconi B. M. Localization of sequence segments forming a kappa-bungarotoxin-binding site on the alpha3 neuronal nicotinic receptor. J. Biol. Chem 1990a; 265: 1537–1544
   PubMed Web of Science ®Google Scholar
• McLane K. E., Wu X., Conti-Tronconi B. M. Identification of a brain acetylcholine receptor alpha subunit able to bind alpha-bungarotoxin. J. Biol. Chem 1990b; 265: 9816–9824
   PubMed Web of Science ®Google Scholar
• McLane K. E., Wu X., Diethelm B. M., Conti-Tronconi B. M. Structural determinants of α-bungarotoxin binding to the sequence segment 181–200 of the muscle nicotinic acetylcholine receptor α subunit: effects of cysteine/cystine modification and species-specific amino acid substitutions. Biochemistr 1991a; 30: 4925–4934
   PubMedGoogle Scholar
• McLane K. E., Wu X., Conti-Tronconi B. M. Amino acid residues forming the interface of a neuronal nicotinic acetylcholine receptor with k-bungarotoxin: a study using single residue substituted peptide analogs. Biochem. Biophys. Res. Commun 1991b; 176: 11–18
   PubMed Web of Science ®Google Scholar
• McLane K. E., Schoepfer R., Wu X., Lindstrom J. M., Conti-Tronconi B. M. Identification of sequence segments forming the α-bungarotoxin binding sites on two nicotinic acetylcholine receptor α subunits from the avian brain. J. Biol. Chem 1991c; 266: 15230–15239
   PubMed Web of Science ®Google Scholar
• McLane K. E., Wu X., Conti-Tronconi B. M. Structural determinants within residues 180–199 of the rodent α5 nicotinic acetylcholine receptor subunit involved in α-bungarotoxin binding. Biochemistr 1991d; 30: 10730–10738
   PubMedGoogle Scholar
• McLane K. E., Weaver W., Lei S., Chiappinelli V. A., Conti-Tronconi B. M. Homologous -neurotoxin exhibit residue-specific interaction α3-subunit of the nicotinic acetylcholine receptor: a comparison of the structural requirements for -bungarotoxin and -flavitoxin binding. Biochemistr 1993; 32: 6988–6994
   Google Scholar
• Melms A., Schalke B. C. G., Kirchner T., Muller-Hermelink H. K., Albert E., Wekerle H. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest 1988; 81: 902–908
   PubMed Web of Science ®Google Scholar
• Melms A., Chrestel S., Schalke B. C. G., Wekerle H., Mauron A., Ballivet M., Barkas T. Autoimmune T lymphocytes in myasthenia gravis: determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. J. Clin. Invest 1989; 83: 785–790
   PubMed Web of Science ®Google Scholar
• Michalek M. T., Banacerraf B., Rock K. L. Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processing. Proc. Natl. Acad. Sci. U.S.A 1989; 86: 3316–3320
   PubMedGoogle Scholar
• Middleton R. E., Cohen J. B. Mapping the acetylcholine binding site of the nicotinic acetylcholine receptor: [3H]nicotine as an agonist photoaffinity label. Biochemistr 1991; 30: 6987–6997
   PubMedGoogle Scholar
• Mihovilovic M., Richman D. P. Monoclonal antibodies as probes of the alpha-bungarotoxin and cholinergic binding regions of the acetylcholine receptor. J. Biol. Chem 1987; 262: 4978–4986
   Google Scholar
• Mihovilovic M., Hulette C., Mittelstaedt J., Austin C., Roses A. D. Nicotinic resonance acetylcholine receptor α-3 subunit transcription in normal and myasthenic thymus. Ann. N.Y. Acad. Sci 1993; 681: 83–96
   Google Scholar
• Miller R. G., Milner-Brown H. S., Dau P. C. Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchange. Muscle Nerv 1981; 4: 255–263
   Google Scholar
• Miller R. J. Genetic manipulation of ion channels: a new approach to structure and mechanisms. Neuro 1989; 2: 1195–1205
   PubMed Web of Science ®Google Scholar
• Mishina M., Kurosaki T., Tobimatsu T., Morimoto Y., Noda M., Yamamoto T., Terao M., Lindstrom J., Takahashi T., Kuno M., Numa S. Expression of functional acetylcholine receptor from cloned cDNAs. Nature (London) 1984; 307: 604–608
   PubMed Web of Science ®Google Scholar
• Mishina M., Tobimatsu T., Imoto K., Tanaka K., Fujita Y., Fukuda K., Kurasaki M., Takahashi H., Morimoto Y., Hirose T., Inayama S., Takahash T., Kuno M., Numa S. Location of functional regions of acetylcholine receptor alpha-subunit by site-directed mutagenesis. Nature (London) 1985; 313: 364–369
   PubMed Web of Science ®Google Scholar
• Mishina M., Toshiyuki T., Imoto K., Noda M., Takahashi T., Numa S., Methfessel C., Sakmann B. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature (London) 1986; 321: 406–411
   PubMed Web of Science ®Google Scholar
• Mitra A. K., McCarthy M. P., Stroud R. M. Three dimensional structure of the nicotinic acetylcholine receptor and location of the major associated 43-kD cytoskeletal protein, determined at 22 Å by low dose electron microscopy and X-ray diffraction to 12.5 Å. J. Cell Biol 1989; 109: 755–774
   Google Scholar
• Moiola L., Karachunski P., Protti M. P., Howard J. F., Jr, Conti-Tronconi B. M. Epitopes on the β subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subject. J. Clin. Invest 1994, in press
   Google Scholar
• Moiola L., Protti M. P., McCormick D., Howard J. F., Jr., Conti-Tronconi B. M. Myasthenia gravis: residues on the α and γ subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes. J. Immunol 1994, in press
   Google Scholar
• Moore H. P. H., Raftery M. A. Ligand induced interconversion of affinity states in membrane-bound acetylcholine receptor from Torpedo californica. Effects of sulfhydryl and disulfide reagents. Biochemistr 1979; 10: 1862–1867
   Google Scholar
• Moore H. P. H., Raftery M. A. Direct spectroscopic studies of cation transport by Torpedo acetylcholine receptor on a time scale of physiological relevance. Proc. Natl. Acad. Sci. U.S.A 1980; 77: 459–4513
   Google Scholar
• Moore C. R., Yates J. R., III, Griffin P. R., Shabanowitz J., Martino P. A., Hunt D. A., Cafiso D. S. Proteolytic fragments of the nicotinic acetylcholine receptor identified by mass spectrometry: implications for receptor topography. Biochemistr 1989; 28: 9184–9191
   PubMed Web of Science ®Google Scholar
• Morgutti M., Conti-Tronconi B. M., Sghirlanzoni A., Clementi F. Cellular immune response to acetylcholine receptor in myasthenia gravis. II. Thymectomy and corticosteroids. Neurolog 1979; 29: 734–738
   Google Scholar
• Mosckovitz R., Gershoni J. M. Three possible disulfides in the acetylcholine receptor alpha-subunit. J. Biol. Chem 1988; 263: 1017–1022
   Google Scholar
• Mossman T. Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1986; 1: 116
   PubMed Web of Science ®Google Scholar
• Mulac-Jericevic B., Atassi M. Z. Segment a (182–190) of the Torpedo californica acetylcholine receptor contains a second toxin binding region and binds anti-receptor antibodies. FEBS Lett 1986; 199: 68–74
   PubMedGoogle Scholar
• Mulac-Jericevic B., Atassi M. Z. Profile of the alpha-bungarotoxin-binding regions on the extracellular part of the alpha-chain of Torpedo californica acetylcholine receptor. Biochem. J 1987; 248: 847–852
   PubMed Web of Science ®Google Scholar
• Müller-Hermelink H. K., Marx A., Geuder K., Kirchner T. H. The pathological basis of thymoma-associated myasthenia gravis. Ann. N.Y. Acad. Sci 1993; 681: 56–65
   Google Scholar
• Myers R. A., Zafaralla G. C., Gray W. R., Abbott J., Cruz L. J., Olivera B. M. α-Conotoxins, small peptide probes of nicotinic acetylcholine receptors. Biochemistr 1991; 30: 9370–9377
   PubMedGoogle Scholar
• Mygland A., Tysnes O. B., Aarli J. A., Flood P. R., Gilhus N. E. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum. J. Neuroimmunol 1992; 37: 1–7
   PubMed Web of Science ®Google Scholar
• Nagappan R., Kletchko S. Myasthenia gravis presenting as a respiratory failure. N.Z. Med. J 1992; 105: 152–161
   Google Scholar
• Nakanishi N., Schneider N. A., Axel R. A. Family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties. Neuro 1990; 5: 569–581
   PubMed Web of Science ®Google Scholar
• Nef P., Oneyser C., Barkas T., Ballivet M. Acetylcholine receptor related genes expressed in the nervous system. Nicotinic Acetylcholine Receptor, A. Maelicke. NATO-ASI, Series H, Springer Verlag, Heidelberg 1986; Vol. 3: 389–415
   Google Scholar
• Nef P., Oneyser C., Alliod C., Couturier S., Ballivet M. Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors. EMBO J 1988; 7: 595–601
   PubMed Web of Science ®Google Scholar
• Neher E. Ion channels for communication between and within cells. Neuro 1992; 8: 605–612
   Google Scholar
• Nelson S., Conti-Tronconi B. M. Adult thymus expresses an embryonic nicotinic acetylcholine receptor-like protein. J. Neuroimmunol 1990; 29: 81–92
   PubMed Web of Science ®Google Scholar
• Neumann D., Gershoni J. M., Fridkin M., Fuchs S. Antibodies to synthetic peptides as probes for the binding site on the alpha subunit of the acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1985; 82: 3490–3493
   Google Scholar
• Neumann D., Barchan D., Safran A., Gershoni J. M., Fuchs S. Mapping of the alpha-bungarotoxin binding site within the alpha subunit of the acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1986a; 83: 3008–3011
   Google Scholar
• Neumann D., Barchan D., Fridkin M., Fuchs S. Analysis of ligand binding to the synthetic dodecapeptide 185–196 of the acetylcholine receptor alpha subunit. Proc. Natl. Acad. Sci. U.S.A 1986b; 83: 9250–9253
   PubMed Web of Science ®Google Scholar
• Neumann D., Barchan D., Horowitz M., Kochva E., Fuchs S. Snake acetylcholine receptor: cloning of the domain containing the four extracellular cysteines of the alpha subunit. Proc. Natl. Acad. Sci. U.S.A 1989; 86: 7255–7259
   PubMedGoogle Scholar
• Nicholas J. A., Levely M. E., Mitchell M. A., Smith C. W. A 16-amino acid peptide of respiratory syncytial virus 1A protein contains two overlapping T cell-stimulating sites distinguishable by class II MHC restriction elements. J. Immunol 1989; 143: 2790–2796
   Google Scholar
• Noda M., Takahashi H., Tanabe T., Toyosato M., Furutani Y., Hirose T., Asai M., Inayama S., Miyata T., Numa S. Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature (London) 1982; 299: 793–797
   PubMed Web of Science ®Google Scholar
• Noda M., Takahashi H., Tanabe T., Toyoto M., Kikyotani S., Hirose T., Asai M., Takasha H., Inayama S., Miyata T., Numa S. Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor. Nature (London) 1983a; 301: 251–255
   PubMed Web of Science ®Google Scholar
• Noda M., Takahashi H., Tanabe T., Toyosato M., Kikyotani S., Furutani Y., Hirose T., Takashima H., Inayama S., Miyata T., Numa S. Primary structures of beta- and delta-subunit precursors of Torpedo californica acetylcholine receptor deduced from cDNA sequences. Nature (London) 1983b; 302: 528–532
   PubMed Web of Science ®Google Scholar
• Noda M., Furutani Y., Takahashi H., Toyosato M., Tanabe T., Shimizu S., Kikyotani S., Kayano T., Kirose T., Inayama S., Numa S. Structural homology of Torpedo californica acetylcholine receptor subunits. Nature (London) 1983c; 302: 818–823
   Google Scholar
• O'Sullivan P. J., Sidney E., Appella L., Uacker L., Phillips S. M., Colon C., Miles R. W., Chestnut, Sette A. Characterization of the specificity of peptide binding to four DR haplotypes. J. Immunol 1990; 145: 1799–1808
   PubMedGoogle Scholar
• O'Sullivan D., Arrhenius T., Sidney M. F., et al. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol 1991; 147: 2663–2669
   PubMed Web of Science ®Google Scholar
• Oberthür W., Hucho F. Photoaffinity labelling of functional states of the nicotinic acetylcholine receptor. J. Protein Chem 1988; 7: 141–150
   Google Scholar
• Oblas B., Singer R. H., Boyd N. D. Location of a polypeptide sequence within the α-subunit of the acetylcholine receptor containing the cholinergic binding site. Mol. Pharmacol 1986; 29: 649–656
   Google Scholar
• Ochoa E. L. M., Chattopadhyay A., McNamee M. G. Desensitization of the acetylcholine receptor: molecular mechanisms and effect of modulators. Cell. Mol. Neurobiol 1989; 9: 141–178
   PubMedGoogle Scholar
• Oda K., Korenaga S., Ito Y. Myasthenia gravis: passive transfer to mice of antibodies to human and mouse acetylcholine receptor. Neurolog 1981; 31: 282–287
   PubMed Web of Science ®Google Scholar
• Oda K. Differences in acetylcholine receptor-antibody interactions between extraocular and extremity muscle fibers. Myasthenia gravis and related disorders. Ann. N.Y. Acad. Sci 1993; 681: 238–255
   Google Scholar
• Oh S. J., Kuruoglu R. Chronic limb-girdle myasthenia gravis. Neurolog 1992; 42: 1153–1156
   Google Scholar
• Ohana B., Gershoni J. M. Comparison of the toxin binding sites of the nicotinic acetylcholine receptor from Drosophila to human. Biochemistr 1990; 29: 6409–6415
   PubMed Web of Science ®Google Scholar
• Ohana B., Fraenkel Y., Navon G., Gershoni J. M. Molecular dissection of cholinergic binding sites: how do snakes escape the effects of their own toxins. Biochem. Biophys. Res. Commun 1991; 179: 648–654
   PubMed Web of Science ®Google Scholar
• Oiki S., Danho W., Madison V., Montal M. M2 δ, a candidate for the structure lining the ionic channel of the nicotinic cholinergic receptor. Proc. Natl. Acad. Sci. U.S.A 1988; 85: 8703–8707
   PubMedGoogle Scholar
• Oldstone M. B. A. Molecular mimicry and autoimmune disease. Cel 1987; 50: 819–820
   PubMed Web of Science ®Google Scholar
• Olivera B. M., Rivier J., Clark C., Ramilo C. A., Corpuz G. P., Abogadie F. C., Mena E. E., Woodward S. R., Hillyard D. R., Cruz L. J. Diversity of Conus neuropeptides. Scienc 1990; 249: 257–263
   PubMed Web of Science ®Google Scholar
• Oshima M., Ashizawa T., Pollack M. S., Atassi M. Z. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit. Eur. J. Immunol 1990; 20: 2563–2569
   PubMed Web of Science ®Google Scholar
• Osserman K. E., Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt. Sinai J. Med 1971; 38: 497–537
   PubMed Web of Science ®Google Scholar
• Oswald R. E., Changeux J. P. Crosslinking of α-bungarotoxin to the acetylcholine receptor from Torpedo marmorata by ultraviolet light irradiation. FEBS Lett 1982; 139: 225–229
   Google Scholar
• Ovadia M., Kochva E. Neutralization of Viperidae and Elapidae snake venoms by sera of different animals. Toxico 1977; 15: 541–548
   PubMedGoogle Scholar
• Pakula A. A., Simon M. I. Determination of transmembrane protein structure by disulfide cross-linking: the Escherichia coli Tar receptor. Proc. Natl. Acad. Sci. U.S.A 1992; 89: 4144–4148
   Google Scholar
• Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol 1989; 19: 2237–2242
   PubMed Web of Science ®Google Scholar
• Papadouli I., Potamianos S., Hadjidakis I., Bairaktari K., Tsikaris K., Sakarellos C., Cung M. T., Marraud M., Tzartos S. J. Antigenic role of a single residue within the main immunogenic region of the nicotinic acetylcholine receptor. Biochem. J 1990; 269: 239–245
   PubMed Web of Science ®Google Scholar
• Papke R. L., Boulter J., Patrick J., Heinemann S. Single channel currents of rat neuronal nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes. Neuro 1989; 3: 589–596
   PubMed Web of Science ®Google Scholar
• Papke R. L., Heinemann S. F. The role of the β4 subunit in determining the kinetic properties of neuronal nicotinic α3 receptors. J. Physiol 1991; 440: 95–112
   Google Scholar
• Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Scienc 1973; 180: 571–573
   Google Scholar
• Pedersen S. E., Dreyer E. B., Cohen J. B. Location of ligand-binding sites on the nicotinic acetylcholine receptor α-subunit. J. Biol. Chem 1986; 261: 13735–13742
   Google Scholar
• Pedersen S. E., Cohen J. B. δ-Tubocurarine binding sites are located at α-γ and α-δ subunit interfaces of the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1990; 87: 2785–2789
   PubMedGoogle Scholar
• Penn A. S., Richman D. P., Ruff R. L., Lennon V. Myasthenia gravis and related disorders. Ann. NY. Acad. Sci. 1993; 681
   Google Scholar
• Pette M., Fujita K., Kitze B., Whitaker J. N., Albert E., Kappos L., Wekerle H. Myelin basic protein-specific T lymphocytes from MS patients and healthy individuals. Neurolog 1990; 40: 1770–1776
   PubMed Web of Science ®Google Scholar
• Poulter L., Earnest J. P., Stroud R. M., Burlingame A. L. Structure, oligosaccharide structures, and posttranslationally modified sites of the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1989; 86: 6645–6649
   Google Scholar
• Pradier L., Yee A. S., McNamee M. G. Use of chemical modification and site-directed mutagenesis to probe the functional role of thiol groups on the gamma subunit of Torpedo californica acetylcholine receptor. Biochemistr 1989; 28: 6562–6571
   Google Scholar
• Protti M. P., Manfredi A. A., Straub C., Howard J. F., Jr., Conti-Tronconi B. M. CD4+ T cell response is the human acetylcholine receptor α subunit in myasthenia gravis. A study with synthetic peptides. J. Immunol 1990; 144: 1276–1281
   PubMed Web of Science ®Google Scholar
• Protti M. P., Manfredi A. A., Straub C., Wu X. D., Howard J. F., Jr., Conti-Tronconi B. M. Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients. J. Immunol. 1990a; 144: 1711
   PubMed Web of Science ®Google Scholar
• Protti M. P., Manfredi A. A., Straub C., Howard J. F., Jr., Conti-Tronconi B. M. Immunodominant regions for T helper sensitization on the human nicotinic receptor α subunit in myasthenia gravis. Proc. Natl. Acad. Sci. U.S.A 1990b; 87: 7792–7796
   Google Scholar
• Protti M. P., Manfredi A. A., Wu X. D., Moiola L., Howard J. F., Jr., Conti-Tronconi B. M. Myasthenia gravis: T epitopes of the δ subunit of human muscle acetylcholine receptor. J. Immunol 1991; 146: 2253–2261
   Google Scholar
• Protti M. P., Manfredi A. A., Howard J. F., Jr., Conti-Tronconi B. M. T cells in myasthenia gravis specific for embryonic acetylcholine receptor. Neurolog 1991b; 41: 1809–1814
   Google Scholar
• Protti M. P., Manfredi A. A., Wu X. D., Moiola L., Dalton M. W. M., Howard J. F., Jr., Conti-Tronconi B. M. Myasthenia gravis. CD4+ T epitopes on the embryonic γ subunit of human muscle acetylcholine receptor. J. Clin. Invest 1992; 90: 1558–1567
   Google Scholar
• Protti M. P., Manfredi A. A., Horton R. M., Bellone M., Conti-Tronconi B. M. Myasthenia gravis: recognition of a human autoantigen at the molecular level. Immunol. Toda 1993; 14: 363–368
   PubMedGoogle Scholar
• Radding W., Corfield P. W. R., Levinson L. S., Hashim G. A., Low B. W. α-Toxin binding to acetylcholine receptor α1 79–191 peptides: intrinsic fluorescence studies. FEBS Lett 1988; 231: 212–216
   Google Scholar
• Raftery M. A., Hunkapiller M. W., Strader C. D., Hood L. E. Acetylcholine receptor: complex of homologous subunits. Scienc 1980; 208: 1454–1457
   PubMed Web of Science ®Google Scholar
• Ralston S., Sarin V., Thanh H. L., Rivier J., Fox L., Lindstrom J. Synthetic peptides used to locate the alpha-bungarotoxin binding site and immunogenic regions on alpha subunits of the nicotinic acetylcholine receptor. Biochemistr 1987; 26: 3261–3266
   PubMed Web of Science ®Google Scholar
• Ratnam M., Lindstrom J. Structural features of the nicotinic acetylcholine receptor revealed by antibodies to synthetic peptides. Biochem. Biophys. Res. Commun 1984; 12: 1225–1233
   Google Scholar
• Ratnam M., Manohar Le Nguyen D., Rivier J., Sargent P. B., Lindstrom J. Transmembrane topography of nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profiles. Biochemistr 1986a; 25: 2633–2643
   PubMed Web of Science ®Google Scholar
• Ratnam N., Sargent P. B., Sarin V., Fox J. L., Nguyen D. L., Rivier J., Criado M., Lindstrom J. M. Location of antigenic determinants on primary sequences of subunit of nicotinic acetylcholine receptors by peptide mapping. Biochemistr 1986b; 25: 2621–2632
   PubMed Web of Science ®Google Scholar
• Ravdin P. M., Berg D. K. Inhibition of neuronal acetylcholine sensitivity by alpha-toxins from Bungarus multicinctus venom. Proc. Natl. Acad. Sci. U.S.A 1979; 76: 2072–2076
   PubMed Web of Science ®Google Scholar
• Revah F., Galzi J. L., Giraudat J., Hauman P. Y., Lederer F., Changeux J. P. The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor γ subunit: implications for the α-helical organization of regions of MII and for the structure of the ion channel. Proc. Natl. Acad. Sci. U.S.A 1990; 87: 4675–4679
   PubMed Web of Science ®Google Scholar
• Revah F., Bertrand D., Galzi J. L., Devillers-Thiery A., Mulle C., Hussy N., Bertrand S., Ballivet M., Changeux J. P. Mutations in the channel domain after desensitization of a neuronal nicotinic receptor. Nature (London) 1991; 353: 846–849
   PubMedGoogle Scholar
• Richman D. P., Gomez M. C., Berman P. W., Burres S. A., Fitch F. W., Arnason B. G. W. Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia. Nature (London) 1980; 286: 738–739
   Google Scholar
• Roses A. D., Olanow C. W., McAdams M. W., Lane R. J. M. No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis. Neurolog 1981; 31: 220–224
   Google Scholar
• Roth B., Schwendimann B., Hughes C. J., Tzartos S. J., Barkas T. A modified nicotinic acetylcholine receptor lacking the ion channel amphipathic helices. FEBS Lett 1987; 221: 172–178
   Google Scholar
• Roszman T. L., Brooks W. H. Neural modulation of immune function. J. Neuroimmunol 1985; 10: 59–72
   PubMed Web of Science ®Google Scholar
• Saedi M. S., Anand R., Conroy W. G., Lindstrom J. M. Determination of amino acids critical to the main immunogenic region of intact acetylcholine receptors by in vitro mutagenesis. FEBS Lett 1990; 267: 55–59
   PubMed Web of Science ®Google Scholar
• Sahash K., Engel A. G., Lamberg E. H., Howard F. N., Jr. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor endplate in myasthenia gravis. Neuropathol. Exp. Neurol 1980; 39: 160–166
   Google Scholar
• Sakai K., Sinha A. A., Mitchell D. J., Zamvill S. S., Rothbard J. B., McDevitt H. O., Steinman L. Involvement of distinct murine T cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc. Natl. Acad. Sci. U.S.A 1988; 85: 8608–8612
   PubMed Web of Science ®Google Scholar
• Sakimura K., Bujo H., Kushiya E., Araki K., Yamazaki M., Megureo H., Warashina A., Numa S., Mishina M. Functional expression from cloned cDNAs of glutamate receptor species responsive to kainate and quisqualate. FEBS Lett 1990; 272: 73–80
   Google Scholar
• Sakimura K., Morita T., Kishiya E., Mishina M. Primary structure and expression of the γ2 subunit of the glutamate receptor channel selective for kainate. Neuro 1992; 8: 267–274
   Google Scholar
• Single-Channel Recording, B. Sakmann, E. Neher. Plenum Press, New York 1983
   Google Scholar
• Sakmann B. Elementary steps in synaptic transmission revealed by currents through single ion channels. Neuro 1992; 8: 613–629
   Google Scholar
• Sawruk E., Udri C., Betz H., Schmitt B. SBD, a novel structural subunit of the Drosophila nicotinic acetylcholine receptor, shares its genomic localization with two alpha-subunits. FEBS Lett 1990a; 273: 177–181
   Google Scholar
• Sawruk E., Scloss P., Betz H., Schmidt B. Heterogeneity of Drosophila nicotinic acetylcholine receptors: SAD, a novel developmentally regulated alpha-subunit. EMBO J 1990b; 9: 2671–2677
   PubMed Web of Science ®Google Scholar
• Schleup M., Willcox N., Vincent A., Dhoot G. K., Newson-Davis J. Acetylcholine receptors in human thymic myoid cells in situ: an immunological study. Ann. Neurol 1987; 22: 212–222
   Google Scholar
• Schlob P., Hermans-Borgmeyer I., Betz H., Gundelfinger E. D. Neuronal acetylcholine receptors in Drosophila: the ARD proton is a component of a high-affinity alpha-bungarotoxin binding complex. EMBO J 1988; 7: 2889–2894
   Google Scholar
• Schoenbeck S., Padberg F., Hohlfeld R., Wekerle H. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis. J. Clin. Invest 1992; 90: 245–250
   Google Scholar
• Schoepfer R., Conroy W. G., Whiting P., Gore M., Lindstrom J. Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuro 1990; 4: 35–48
   Google Scholar
• Schoepfer R., Whiting P., Esch F., Blacher R., Shimasaki S., Lindstrom J. cDNA clones coding for the structural subunit of a chick brain nicotinic acetylcholine receptor. Neuro 1988; 1: 241–248
   PubMedGoogle Scholar
• Schoepfer R., Luther M., Lindstrom J. The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor: cloning of the α subunit cDNA. FEBS Lett 1988; 226: 235–240
   Google Scholar
• Schönbeck S., Chrestel S., Hohlfeld R. Myasthenia gravis: prototype of the antireceptor autoimmune diseases. Intl. Rev. Neurobiol 1990; 32: 175–200
   Google Scholar
• Schuetze S. M. Embryonic and adult acetylcholine receptor: molecular basis of development changes in ion channel properties. Trends Newosci 1986; 9: 386–388
   Google Scholar
• Schumacher J., Roth J. Thymektomic bei einem Fall von Morbus Basedowi mit Myasthenia. Mitt Grenzgeb. Med. Clin 1913; 25: 745–749
   Google Scholar
• Schumacher M., Camp S., Maulet Y., Newton M., Macphee-Quigley K., Taylor S. S., Friedman T., Taylor P. Primary structure of Torpedo acetylcholinesterase deduced from its cDNA sequence. Nature (London) 1986; 319: 407–409
   PubMed Web of Science ®Google Scholar
• Simpson J. A. Myasthenia gravis, a new hypothesis. Scott. Med. J. 1960; 5: 419
   Google Scholar
• Sine S. M., Claudio T. γ and δ-subunits regulate the affinity and the cooperativity of ligand binding to the acetylcholine receptor. J. Biol. Chem 1991; 266: 19369–19377
   Google Scholar
• Smart L., Meyers H. W., Hilginfeld R., Saenger W., Maelicke A. A structural model for the ligand-binding sites at the nicotinic acetylcholine receptor. FEBS Lett 1984; 178: 64–68
   Google Scholar
• Smith M. A., Stilberg J., Lindstrom J. M., Berg D. K. Characterization of a component in chick ciliary ganglia that crossreacts with monoclonal antibodies to muscle and electric organ acetylcholine receptor. J. Neurosci 1985; 5: 2726–2731
   Google Scholar
• Sommer B., Burnashev N., Verdoorn T. A., Keinanen K., Sakmann B., Seeburg P. H. A glutamate receptor channel with high affinity for domoate and kainate. EMBO J. 1992, in press
   Google Scholar
• Sommer N., Harcourt G. C., Willcox N., Beeson D., Newsom-Davis J. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurolog 1991; 41: 1270–1275
   PubMed Web of Science ®Google Scholar
• Stader C. B. D., Revel J. P., Raftery M. A. Demonstration of the transmembrane nature of the acetylcholine receptor by labeling with anti-receptor antibodies. J. Cell Biol 1979; 83: 499–510
   Google Scholar
• Stroud R. M., McCarthy M. P., Shuster M. Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels. Biochemistr 1990; 29: 11009–11023
   PubMed Web of Science ®Google Scholar
• Sumikawa K., Miledi R. Change in desensitization of cat muscle acetylcholine receptor caused by coexpression of Torpedo acetylcholine receptor sub-units in Xenopus oocytes. Proc. Natl. Acad. Sci. U.S.A 1989; 86: 367–371
   Google Scholar
• Sumikawa K., Gehle V. M. Assembly of mutant subunits of the nicotinic acetylcholine receptor lacking the conserved disulfide loop structure. J. Biol. Chem 1992; 267: 6286–6290
   Google Scholar
• Sun J. B., Harcourt G., Wang Z. Y., et al. T cell responses to human recombinant acetylcholine receptor α subunit in myasthenia gravis and controls. Eur. J. Immunol 1992; 22: 1553–1559
   PubMed Web of Science ®Google Scholar
• Sussman J. L., Harel M., Frolow F., Oefner C., Goldman A., Toker L., Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Scienc 1991; 253: 872–879
   PubMed Web of Science ®Google Scholar
• Takai T., Noda M., Furutani Y., Takahashi H., Notake M., Shimizu S., Kayano T., Tanabe T., Tanaka K., Hirose T., Inayama S., Numa S. Primary structure of γ-subunit precursor of calf muscle acetylcholine receptor deduced from cDNA sequence. Eur. J. Biochem 1984; 143: 109–115
   PubMedGoogle Scholar
• Takai T., Noda M., Mishina M., Shimizu S., Furutani Y., Kayano T., Ikeda T., Kubo T., Takahashi H., Takahashi T., Kuno M., Numa S. Cloning, sequencing and expression of cDNA for a novel subunit of acetylcholine receptor from calf muscle. Nature (London) 1985; 315: 761–764
   PubMed Web of Science ®Google Scholar
• Tanabe T., Noda M., Furutani Y., Takai T., Takahashi H., Tanaka K., Hirose T., Inayama S., Numa S. Primary structure of β subunit precursor of calf muscle acetylcholine receptor deduced from cDNA sequence. Eur. J. Biochem 1984; 144: 11–17
   PubMedGoogle Scholar
• Tine S. J., Raftery M. A. Use of a cholinergic photoaffinity reagent to delineate multi-subunit involvement in binding sites of low and high affinity on Torpedo acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1993; 90: 7308–7311
   Google Scholar
• Todd A. P., Cong J., Levinthal F., Levinthal C., Hubbell W. Site-directed mutagenesis of colicin E1 provides specific attachment sites for spin labels whose spectra are sensitive to local conformation. Protein 1989; 6: 294–305
   PubMed Web of Science ®Google Scholar
• Tomaselli G. F., McLaughlin J. T., Jurman M. E., Hawrot E., Yellen G. Mutations affecting agonist sensitivity of the nicotinic acetylcholine receptor. Biophys. J 1991; 60: 721–724
   PubMed Web of Science ®Google Scholar
• Tomaselli G. F., McLaughlin J. T., Jurman M. E., Hawrot E., Yellen G. Mutations affecting agonist sensitivity of the nicotinic acetylcholine receptor. Biophys. J 1991; 60: 721–724
   PubMed Web of Science ®Google Scholar
• Toyka K. V., Drachman D. B., Pestronk A., Kao I. Myasmenia gravis: passive transfer from man to mouse. Scienc 1975; 190: 397–400
   PubMed Web of Science ®Google Scholar
• Trautman A. Curare can open and block ionic channels associated with cholinergic receptors. Nature (London) 1982; 298: 272–275
   Google Scholar
• Tzartos S. J., Lindstrom J. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc. Natl. Acad. Sci. U.S.A 1980; 77: 755–759
   PubMed Web of Science ®Google Scholar
• Tzartos S. J., Rand D. E., Einarson B. E., Lindstrom J. M. Mapping of surface structures of Electrophorus acetylcholine receptor using monoclonal antibodies. J. Biol. Chem 1981; 256: 8635–8645
   PubMed Web of Science ®Google Scholar
• Tzartos S. J., Seybold M., Lindstrom J. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A 1982; 79: 188–191
   PubMed Web of Science ®Google Scholar
• Tzartos S. J., Changeux J. P. High affinity binding of alpha-bungarotoxin to the purified alpha-subunit and to its 27000-dalton proteolytic peptide from Torpedo marmorata acetylcholine receptor. Requirement for the sodium dodecyl. EMBO J 1983; 2: 381–387
   PubMed Web of Science ®Google Scholar
• Tzartos S. J., Langeberg L., Hochsehwender S., Lindstrom J. M. Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor. FEBS Lett 1983a; 158: 116–118
   PubMed Web of Science ®Google Scholar
• Tzartos S. J., Sophianos D., Efthimiadis A. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera. J. Immunol 1985; 134: 2343–2349
   PubMed Web of Science ®Google Scholar
• Tzartos S. J., Starzinski-Powitz A. Decrease in acetylcholine receptor content of human myotube cultures mediated by monoclonal antibodies to α, β and γ subunits. FEBS Lett 1986; 196: 91–95
   PubMed Web of Science ®Google Scholar
• Tzartos S., Hochsehwender S., Vasquez P., Lindstrom J. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J. Neuroimmunol 1987; 15: 185–190
   PubMed Web of Science ®Google Scholar
• Tzartos S., Kokla A., Walgrave S., Conti-Tronconi B. M. The main immunogenic region of human muscle acetylcholine receptor is localized within residues 67–76 of the α subunit. Proc. Natl. Acad. Sci. U.S.A 1988; 85: 2899–2903
   PubMed Web of Science ®Google Scholar
• Tzartos S. J., Remoundos M. S. Fine localization of the major α-bungarotoxin binding site to residues α189–195 of the Torpedo acetylcholine receptor: residues 189, 190, and 195 are indispensable for binding. J. Biol. Chem 1990; 265: 21462–21467
   PubMedGoogle Scholar
• Tzartos S. J., Loutrari H. V., Tang F., Kokla A., Walgrave S. L., Milius R. P., Conti-Tronconi B. M. Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor: localization and microheterogeneity revealed by the use of synthetic peptides. J. Neurochem 1990a; 54: 51–61
   PubMed Web of Science ®Google Scholar
• Ueno S., Wada K., Takahashi M., Tarui S. Acetylcholine receptor in rabbit thymus: antigenic similarity between acetylcholine receptors of muscle and thymus. Clin. Exp. Immunol 1980; 42: 463–469
   Google Scholar
• Unwin N., Toyosha C., Kubalek E. Arrangement of the acetylcholine receptor subunits in the resting and desensitized states, determined by cryoelectron microscopy of crystallized Torpedo postsynaptic membranes. J. Cell. Biol 1988; 107: 1123–1138
   Google Scholar
• Unwin P. N. T., Ennis P. D. Two configurations of a channel forming membrane protein. Nature (London) 1984; 307: 609–613
   PubMed Web of Science ®Google Scholar
• Van De Velde R. L., Friedman N. B. The thymic “Myodzellen” and myasthenia gravis. JAM 1966; 198: 287–288
   Google Scholar
• Van Der Geld H. W. R., Strauss A. J. L. Myasthenia gravis: immunological relationship between striated muscle and thymus. Lance 1966; i: 57–60
   Google Scholar
• Vincent A., Whiting P. J., Schleup M., et al. Antibody heterogeneity and specificity in myasthenia gravis. Ann. N.Y. Acad. Sci 1987; 505: 106–120
   PubMedGoogle Scholar
• Wada K., Ballivet M., Boulter J., Connolly J., Wada E., Deneris E. S., Swanson L. W., Heinemann S., Patrick J. Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptor. Scienc 1988; 240: 330–334
   PubMed Web of Science ®Google Scholar
• Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L. W. Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol 1989; 284: 314–35
   PubMed Web of Science ®Google Scholar
• Wahlsten J. L., Lindstrom J. M., Ostlie N., Wu X. D., Conti-Tronconi B. M. Myasthenia gravis: effect of antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor. J. Recept. Res 1993; 13: 863–879
   Web of Science ®Google Scholar
• Wahlsten J. L., Lindstrom J. M., Conti-Tronconi B. M. Amino acid residues within the sequence region α55–74 of Torpedo nicotinic acetylcholine receptor interacting with antibodies to the main immunogenic region and with snake α-neurotoxins. J. Recept. Res 1993; 13: 989–1008
   PubMed Web of Science ®Google Scholar
• Waldor M. K., Sriram S., McDevitt H. O., Steinman L. In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1983; 80: 2713–2717
   PubMed Web of Science ®Google Scholar
• Walker J. W., Lukas R. J., McNamee M. G. Effects of thio-group modifications on the ion permeability control and ligand binding properties of Torpedo californica acetylcholine receptor. Biochemistr 1981; 20: 2191–2199
   PubMed Web of Science ®Google Scholar
• Walker M. Treatment of myasthenia gravis with physostigmine. Lancet 1934; 1: 1200
   Google Scholar
• Walters D., Maelicke A. Organization of ligand binding sites at the acetylcholine receptor: a study with monoclonal antibodies. Biochemistr 1983; 22: 1811–1819
   Google Scholar
• Weigart G. The thymus in myasthenia gravis. Neurol. Zentrabl. 1901; 20: 597
   Google Scholar
• Weinberg C. B., Hall Z. W. Antibody from patients with myasthenia gravis recognizes determinants unique to extrajunctional acetylcholine receptors. Proc. Natl. Acad. Sci. U.S.A 1979; 76: 504–508
   PubMed Web of Science ®Google Scholar
• Werner P., Voigt M., Keinanen K., Wisden W., Seeburg P. H. Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature (London) 1991; 351: 742–744
   PubMed Web of Science ®Google Scholar
• Wheatley L. M., Urso D., Zheng Y., Loh E., Levinson A. I. Molecular analysis of intrathymic nicotinic acetylcholine receptor. Ann. N.Y. Acad. Sci 1993; 681: 74–82
   Google Scholar
• Whiting P. J., Lindstrom J. M. Purification and characterization of a nicotinic acetylcholine receptor from chick brain. Biochemistr 1986; 25: 2082–2093
   PubMedGoogle Scholar
• Whiting P. J., Lindstrom J. M. Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc. Natl. Acad. Sci. U.S.A 1987; 84: 595–599
   PubMed Web of Science ®Google Scholar
• Whiting P., Lu R., Morley B. J., Lindstrom J. M. Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies. J. Neurosci 1987; 7: 4005–4016
   PubMedGoogle Scholar
• Whiting P. J., Lindstrom J. M. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J. Neurosci 1988; 8: 3395–3404
   PubMedGoogle Scholar
• Whiting P., Schoepfer R., Lindstrom J., Priestley T. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol. Pharmacol 1991; 40: 463–472
   PubMedGoogle Scholar
• Willcox N., Baggi F., Batocchi A. P., Beeson D., Hartcourt G., Hawke S., Jacobson L., Matsuo H., Moody A. M., Nagvekar N., Nicolle M., Og B., Pantic N., Newsom-Davis J., Vincent A. Approaches for studying the pathogenic T cells in autoimmune patients. Ann. N.Y. Acad. Sci 1993; 681: 219–237
   PubMed Web of Science ®Google Scholar
• Williams J. M., Felten D. L. Sympathetic innervation of murine thymus and spleen: a comparative histofluorescence study. Anat. Rec 1981; 199: 513–539
   Google Scholar
• Willis T. De anima brutorum as quoted in Living with Myasthenia Gravis, J. W. Kempton. Charles C Thomas, Springfield, IL 1672; 5
   Google Scholar
• Wilson P. T., Gershoni J. M., Hawrot E., Lentz T. L. Binding of alpha-bungarotoxin to proteolytic fragments of the alpha subunit of Torpedo acetylcholine receptor analyzed by protein transfer on positively charged membrane filters. Proc. Natl. Acad. Sci. U.S.A 1984; 81: 2553–2557
   Google Scholar
• Wilson P. T., Lentz T. L., Hawrot E. Determination of the primary amino acid sequence specifying the alpha-bungarotoxin binding site on the alpha sub-unit of the acetylcholine receptor fro. Torpedo californica. Proc. Natl. Acad. Sci. U.S.A 1985; 82: 8790–8794
   Google Scholar
• Wilson P. T., Lentz T. L. Binding of alpha-bungarotoxin to synthetic peptides corresponding to residues 173–204 of the alpha subunit of Torpedo calf and human acetylcholine receptor and restoration of high-affinity binding by sodium dodecyl sulfate. Biochemistr 1988; 27: 6667–6674
   PubMed Web of Science ®Google Scholar
• Wilson P. T., Hawrot E., Lentz T. L. Distribution of alpha-bungarotoxin binding sites over residues 173–204 of the alpha subunit of the acetylcholine receptor. Mol. Pharmacol 1988; 34: 643–651
   PubMed Web of Science ®Google Scholar
• Witzemann V., Raftery M. A. Selective photoaffinity labeling of acetylcholine receptor using a cholinergic analogue. Biochemistr 1977; 16: 5862–5868
   Google Scholar
• Witzemann V., Raftery M. A. Affinity directed crosslinking of acetylcholine receptor in postsynaptic membranes. Biochem. Biophys. Res. Commun 1979; 85: 623–628
   Google Scholar
• Witzemann V., Muchmore D., Raftery M. A. Affinity directed crosslinking of membrane-bound acetylcholine receptor polypeptides with photolabile 1972.-bungarotoxin derivatives. Biochemistr 1979; 18: 5511–5520
   Google Scholar
• Wu W., Moore H. P., Raftery M. A. Quantitation of cation transport by reconstituted membrane vesicles containing purified acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A 1981; 78: 775–780
   PubMed Web of Science ®Google Scholar
• Yee A. S., Corley D. E., McNamee M. G. Thiol-group modification of Torpedo californica acetylcholine receptor: subunit localization and effects on function. Biochemistr 1986; 25: 2110–2119
   Google Scholar
• Young E. F., Ralston E., Blake J., Ramachandran J., Hall Z. H., Stroud R. M. Topological mapping of acetylcholine receptor: evidence for a model with five transmembrane segments and a cytoplasmic COOH-terminal peptide. Proc. Natl. Acad. Sci. U.S.A 1985; 82: 626–630
   Google Scholar
• Zhang Y., Schleup M., Frutiger S., Hughes G. J., Jaenner M., Steek A., Barkas T. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients. Eur. J. Immunol 1990; 20: 2577–2583
   PubMed Web of Science ®Google Scholar